Skip to content
Lower risk Drug recall · FDA · Published August 23, 2022

Leading Pharma recalls 25mg Clomipramine capsules with high drug content

Leading Pharma recalls 25mg Clomipramine hydrochloride capsules (NDC 69315-167-01) due to higher-than-stated drug content. This may cause overdose risk if taken as prescribed.

🇺🇸 FDA recall #D-1546-2022DrugLeading Pharma ›
Take action

Contact the company

Recalling firmLeading Pharma, LLC3 Oak Rd · Fairfield, NJ 07004-2903
✎ GovInfoNow plain-language explainer

What happened, in plain English

Leading Pharma is recalling 25mg Clomipramine hydrochloride capsules because they contain 110.6% of the labeled drug amount. This could lead to overdose if taken as directed, especially since these are prescription-only medications. Read more at govinfonow.com/recall/34358-leading-pharma-recalls-25mg-clomipramine-capsules-with-high-drug-content.

Source Summary by GovInfoNow · govinfonow.com/recall/34358-leading-pharma-recalls-25mg-clomipramine-capsules-with-high-drug-content · Updated August 18, 2026 · FDA enforcement record: FDA #D-1546-2022

Cite this page

“Leading Pharma recalls 25mg Clomipramine capsules with high drug content.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34358-leading-pharma-recalls-25mg-clomipramine-capsules-with-high-drug-content. Based on FDA recall #D-1546-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1546-2022%22&limit=1).

Why it’s dangerous

The capsules contain 110.6% of the labeled drug amount, meaning each capsule has more active ingredient than specified. This could lead to an overdose if taken as directed, though the risk is low since these are prescription-only medications.

Who’s affected

Prescription patients who have the specific 25mg capsules with NDC 69315-167-01. Those most at risk are individuals who might take more than intended due to the higher drug content.

How to tell if you have this one

Check for the product name 'Clomipramine Hydrochloride Capsules, USP 25mg', 100-count bottles, manufactured by Leading Pharma, LLC, with NDC 69315-167-01 and lot number B14221.

  • Brand
    Leading Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product label includes NDC 69315-167-01 and lot number B14221.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Aug 23, 202212. FDA classified it Class III: Sep 28, 202223. Published in FDA’s Enforcement Report: Oct 5, 202234. FDA terminated the recall: Sep 28, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Leading Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1546-2022 (August 23, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1546-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA